[ad_1]
NEW DELHI: A laboratory of the Scientific and Industrial Research Council (CSIR) that developed ‘Feluda’, a paper-based test strip for Covid-19 named after the fictional detective created by Satyajit Ray, teamed up with Tata on Tuesday. Hijos for its deployment and widespread use for rapid mass ground tests later this month.
A completely indigenous scientific invention, ‘Feluda’ has been designed to mitigate the current situation of Covid-19 and to attend to massive tests. Its main advantages are its affordability, relative ease of use and non-dependence on expensive Q-PCR machines.
The ‘Feluda’ is developed by the CSIR Institute for Genomics and Integrative Biology (IGIB).
Lockdown 3.0: latest updates
“CSIR labs like CSIR-IGIB have been working on deep science and developing cutting edge technology and I am happy to see that the leading industry, the TATA Group, is partnering for its deployment. Strong partnership with industry to address the new coronavirus has been the hallmark of CSIR’s strategy in mitigating Covid1-9, “said Shekhar C Mande, CEO of CSIR.
Sons CSIR-IGIB and TATA have signed a memorandum of understanding to license knowledge related to the “development of a kit for rapid and accurate diagnosis” of Covid-19.
More about Covid-19
[ad_2]
A completely indigenous scientific invention, ‘Feluda’ has been designed to mitigate the current situation of Covid-19 and to attend to massive tests. Its main advantages are its affordability, relative ease of use and non-dependence on expensive Q-PCR machines.
The ‘Feluda’ is developed by the CSIR Institute for Genomics and Integrative Biology (IGIB).
Lockdown 3.0: latest updates
“CSIR labs like CSIR-IGIB have been working on deep science and developing cutting edge technology and I am happy to see that the leading industry, the TATA Group, is partnering for its deployment. Strong partnership with industry to address the new coronavirus has been the hallmark of CSIR’s strategy in mitigating Covid1-9, “said Shekhar C Mande, CEO of CSIR.
Sons CSIR-IGIB and TATA have signed a memorandum of understanding to license knowledge related to the “development of a kit for rapid and accurate diagnosis” of Covid-19.
More about Covid-19
“We are pleased to establish a partnership with IGIB of CSIR for further development and commercialization of the technology based on regularly cross-linked short palindromic repeats (CRISPR) for the detection of Covid-19,” said Banmali Agrawala, president of Infrastructure and Defense and Aerospace , Tata Children.
Speaking of the groundbreaking “Feluda” CRISPR test, he said, “It uses a test protocol that is simple to administer and easy to interpret, allowing the results to be available to the medical fraternity in a relatively shorter time, compared to other protocols. test”.
